© Oncology Nursing Society. Unauthorized reproduction, in part or in whole, is strictly prohibited. For permission to photocopy, post online, reprint, adapt, or otherwise reuse any or all content from this article, e-mail pubpermissions@ons.org. To purchase high-quality reprints, email reprints@ons.org.

 

May 2012, Volume 39, Number 3

 

People & Events

Linda K. Morse, RN, MSN • Associate Editor

 

International Society of Nurses in Genetics Honors

Oncology Nursing Society Member

 

Oncology Nursing Society (ONS) member Suzanne Mahon, RN, DNSc, AOCN®, APNG,  a clinical professor in the Department of Internal Medicine and the School of Nursing at St. Louis University in Missouri, received the International Society of Nurses in Genetics (ISONG) Founders’ Education Award. The purpose of the award is to honor an ISONG member who demonstrates excellence in nursing or patient education in genomics. Criteria include outstanding accomplishments related to the education of nurses, patients, or other health professionals; creation and dissemination of media or curricula; teaching genomics; and the dissemination of genomics education innovations and research through publication in peer-reviewed nursing and healthcare literature or presentation to professional and lay audiences.

 

Mahon has been a leader in cancer genetics education and practice for the past 20 years. She has published more than 90 journal articles in addition to several books and book chapters related to cancer risk assessment, genomics education, genetics nursing, hereditary cancer syndromes, and providing competent genetic and genomic care. She also served for several years as an associate editor of the Clinical Journal of Oncology Nursing. Her contributions to genetic and genomic education include extensive development and dissemination of case studies, continuing education modules, and other educational materials including the ONS Breast Cancer and Cancer Genetics online courses. She also has received numerous funded grants to provide individualized genetic education services to patients and families related to genetic counseling and testing for hereditary cancer.

 

Mahon was among the first advanced practice nurses to establish a cancer genetics program and provide cancer risk assessment, genetic counseling, and testing for hereditary cancer. In 2001, she was one of the first 13 advanced practice nurses to become credentialed through the Genetic Nursing Credentialing Commission.

 

Mahon holds long-time dual appointments with the School of Medicine and the School of Nursing at St. Louis University and has primary responsibility for developing and teaching the genomics courses and curricula where she holds appointments. She has been teaching nurses, medical students, and other health professionals for the past 20 years, in addition to providing extensive mentorship through the cancer genetics program she developed and manages. Her work has been used as a model in the development of other programs.

 

For more information, visit www.isong.org/ISONG_awards.php.

 

Society for Integrative Oncology Elects First Nurse President

 

ONS member Susan Bauer-Wu, PhD, RN, FAAN, an associate professor in the Nell Hodgson Woodruff School of Nursing at Emory University in Atlanta, GA, and a Georgia Cancer Coalition Distinguished Scholar, has assumed the role of president-elect of the Society for Integrative Oncology. Bauer-Wu also is the author of a new book, Leaves Falling Gently: Living Fully With Serious and Life-Limiting Illness Through Mindfulness, Compassion, and Connectedness (New Harbinger Publications).

 

The Society for Integrative Oncology is  a multidisciplinary international professional organization dedicated to advancing evidence and improving cancer care through the use of integrated complementary modalities. Bauer-Wu is the first nurse to serve as president-elect.

 

For more information, visit www.integrativeonc.org.

 

ONS Member Named 2011 Healthcare Executive of the Year

 

ONS member Margaret A. O’Grady, RN, MSN, OCN®, FAAMA, senior director of Fox Chase Cancer Center Partners Program in Philadelphia, PA, was named the 2011 Healthcare Executive of the Year by the American Academy of Medical Administrators (AAMA). The Healthcare Executive of the Year Award is AAMA’s highest honor. It recognizes an individual whose work has provided an environment for delivering the maximum level of quality care with dignity and human concern.

 

As director of the the clinical operations staff for the Fox Chase Cancer Center Partners Program, O’Grady coordinates clinical program planning, disease management project development, quality improvement, and hospital-specific accreditations for 25 community hospitals affiliated with Fox Chase. She has a strong background in research, including quality improvement, clinical operations, grants, medical treatment trials, and regulatory issues. She has written and coauthored numerous articles and lectured and presented poster sessions at many national conferences.

 

O’Grady was part of the team responsible for building Fox Chase Cancer Center Partners, the first community cancer affiliate program in the United States. In addition, she has developed quality metrics and processes for an eHealth Radiology-Based Health Information Exchange, a three-way Web-based referral process for clinicians referring patients to the Fox Chase Cancer Center Partners Program, and has led the initiative to effectively deploy Fox Chase physician expertise and unique specialty cancer services at Fox Chase Cancer Center Partner sites. 

 

As a healthcare leader, O’Grady is committed to providing leadership for the development of the profession and to improving the quality of oncology care. She is Six Sigma certified and holds an MSN in Nursing from LaSalle University in Philadelphia. She maintains her oncology nursing certification, is a fellow in the American Academy of Medical Administrators, and is completing her term as president of the American College of Oncology Administrators. She is on the Public Policy Team for Cancer Survivorship White Paper Development for the American Cancer Society, George Washington Institute/Lance Armstrong Initiative, and is the secretary-treasurer of the Pennsylvania Society of Oncology and Hematology.

 

For more information, visit www.aameda.org.

 

2012 Lilly Oncology on Canvas Art Competition Calls for Entries

 

Lilly Oncology and the National Coalition for Cancer Survivorship (NCCS) announced the launch of the 2012 Lilly Oncology on Canvas: Expressions of a Cancer Journey Art Competition and Exhibition. The biennial competition invites individuals from the United States, Puerto Rico, and Canada who were diagnosed with any type of cancer—as well as their families, friends, caregivers, and healthcare providers—to express, through art and narrative, the life-affirming changes that give their cancer journeys meaning. Entries must be postmarked by June 29, 2012.

 

Oncology on Canvas, which provides the cover artwork for the Oncology Nursing Forum, was launched in 2004 by Lilly Oncology to help those affected by cancer cope with the emotional side of the disease. Winners’ prizes consist of donations made to the cancer charities of their choice.

 

Since its inception, Lilly Oncology on Canvas has received more than 3,600 entries. However, those stories represent only a few of the many waiting to be told by the almost 12 million cancer survivors living in the United States alone, in addition to millions of others who love and care for them, according to Newt Crenshaw, vice president of  Lilly Oncology.

 

“If you or someone you care for has heard the three words, ‘You have cancer,’ then you know firsthand that a cancer diagnosis can change the lives of patients and everyone around them,” said Crenshaw. “Lilly Oncology on Canvas has become an important way for cancer patients, oncologists, oncology nurses, and so many others to share their stories of hope and despair, loss and survival, and countless other emotions.”

 

“We are whole people, comprised of biological, spiritual, emotional, and psychological parts,” said NCCS Chair Richard Payne, MD, an international expert in the areas of pain relief, care for those near death, oncology, and neurology. “Oncology on Canvas recognizes this fact by providing anyone affected by cancer with a platform to express often unspoken emotions, resulting in artwork that moves and inspires.”

 

The 2012 Lilly Oncology on Canvas competition has three entrant categories: person diagnosed with cancer; family member, friend, or caregiver; and healthcare professional. Original artwork that depicts one’s cancer journey may be submitted in one of six media: watercolor, oil, pastel, photography, acrylic, or mixed media. The artwork must be accompanied by a narrative. 

 

Winners in 24 categories will be chosen by an independent panel of judges. Prizes consist of donations to cancer-related charities selected by the winners, ranging from $1,000–$10,000. Following the competition, much of the artwork will embark on a tour of cancer centers, hospitals, and patient advocacy group events. 

 

For more information, including official rules, entry forms, and a gallery of previous entries, visit www.lillyoncologyoncanvas.com.

 

GE Healthcare Sponsors Oncology Innovation Awards

 

The Association of Community Cancer Centers (ACCC) announced that GE Healthcare, a unit of General Electric Company, will sponsor the annual ACCC Innovator Awards, which honor member programs that have exhibited forward-thinking strategic planning and developed pioneering programs and replicable models. The 2011 ACCC Innovator Award winners developed new solutions in areas such as strategic planning processes, reducing tobacco-related illness, telepharmacy, and ways to meet the oncology-related fertility needs of patients with cancer. Award winners shared the goals of improving access, quality, and cost-effectiveness of cancer care.

 

GE Healthcare offers a wide portfolio for oncology and a strategy that combines cellular research, medical imaging, laboratory diagnostics, biopharmaceutical manufacturing technologies, and information technology. Those innovative technologies help the oncology community increase their understanding of the causes and progression of cancer and can help physicians make more personalized cancer treatment and management decisions.

 

For more information, visit www.accc-cancer.org.

 

Linda K. Morse, RN, MSN, can be reached at Linda_Morse@dfci.harvard.edu, with copy to editor at ONFEditor@ons.org.

 

http://dx.doi.org/10.1188/12.ONF.243-244